Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Antibiotic Selection

Antibiotic Selection

Inhibitors of Gram-positive Cell Wall Synthesis

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infection.

Open forum infectious diseases·2022

Same author

Validity of 2020 vancomycin consensus recommendations and further guidance for practical application.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2021

Same author

Questions on Vancomycin Dosing.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020

Same author

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2020

Same author

Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Pharmacotherapy·2020

Same author

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2020

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Vancomycin: understanding its past and preserving its future.

Donald P Levine¹

¹Department of Medicine, Wayne State University, Detroit, MI 48201, USA. dlevine@med.wayne.edu

Southern Medical Journal

|March 28, 2008

Summary

Increased vancomycin use led to vancomycin-resistant enterococcus and Staphylococcus aureus. Prudent vancomycin use and infection control are crucial to preserve its efficacy against emerging resistant strains.

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Related Experiment Videos

Last Updated: Jul 6, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Area of Science:

Microbiology
Infectious Diseases
Pharmacology

Background:

The widespread use of vancomycin since the 1980s for treating antibiotic-associated colitis and methicillin-resistant Staphylococcus aureus (MRSA) has driven the emergence of resistance.
Vancomycin-resistant enterococcus (VRE) has appeared, leading to isolated cases of vancomycin-resistant Staphylococcus aureus.
Heteroresistant MRSA strains, which are difficult to detect, pose a significant clinical challenge.

Purpose of the Study:

To highlight the link between vancomycin usage and the rise of antibiotic resistance.
To emphasize the importance of appropriate vancomycin use and infection control measures.
To discuss the potential role of alternative antibiotics in managing vancomycin-resistant infections.

Main Methods:

Literature review and analysis of historical antibiotic usage trends.
Examination of the mechanisms and clinical implications of vancomycin resistance.
Assessment of emerging resistance patterns in Staphylococcus aureus and enterococcus.

Main Results:

Vancomycin use is directly correlated with the increased prevalence of vancomycin resistance in enterococcus and Staphylococcus aureus.
Heteroresistance in MRSA presents a diagnostic and therapeutic challenge.
The efficacy of vancomycin is threatened by escalating resistance.

Conclusions:

Judicious vancomycin use and strict adherence to infection control protocols are essential to mitigate the development of vancomycin resistance.
Alternative antibiotics like linezolid, quinupristin/dalfopristin, daptomycin, and tigecycline may become increasingly important for treating infections caused by vancomycin-resistant pathogens.
Preserving the future efficacy of vancomycin requires a concerted effort to minimize resistance development.